The Valley Desk

NCT04102098 · Interventional trial

A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Overall registry status Completed

Phase 3

Conditions Carcinoma, Hepatocellular

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov